A woman from WA has become the second Australian to suffer a rare blood clotting condition after receiving the AstraZeneca vaccine.
The woman aged in her 40s is in a stable condition in hospital after being diagnosed with a case of “thrombosis with thrombocytopenia”.
The Therapeutic Goods Administration (TGA) issued a statement on Tuesday and said the case is "likely to be linked to the vaccination".
"The panel concluded that the case is similar to cases seen in Europe and the United Kingdom of a rare clotting disorder, referred to as 'thrombosis with thrombocytopenia syndrome' (TTS)."
There have been about 700,000 doses of AstraZeneca vaccines administered in Australia to date.
The second case now means one in 350,000 AstraZeneca vaccinations administered in the country have potential ties to blood clots.
"The TGA is carefully reviewing all Australian reports of blood clots following the AstraZeneca vaccine," the statement read.
People who have received the vaccine should seek immediate medical attention if they develop symptoms such as a severe or persistent headache, blurred vision, shortness of breath, chest pain, leg swelling or unusual skin bruising and/or pinpoint round spots beyond the site of injection.
Police issue 31,000 driving infringements in first month of new AI cameras
Works underway on Rockingham and Safety Bay High School redevelopments
New measles exposure sites revealed in Bunbury
Dawesville man charged after allegedly leaving his elderly Great Dane to suffer painful conditions
Good Samaritan sought by police after helping teen during robbery in Baldivis
Under-16s social media ban now in force
Desperate search continues for missing Bunbury FIFO worker
Passengers now able to use credit, debit cards to tag on and off WA's public transport
New floating jetty speeds up emergency response times for Marine Rescue Mandurah